Radiosensitization of non-small cell lung carcinoma by EGFR inhibition

Autor: Giuseppe Privitera, M Tanja Bulat, D Otilija Keta, J Jelena Zakula, M Aleksandra Ristic-Fira, B Lela Koricanac, Giacomo Cuttone, M Ivan Petrovic

Publikováno v: Nuclear technology and radiation protection
Nuclear Technology and Radiation Protection, Vol 29, Iss 3, Pp 233-241 (2014)

Molecular targeted cancer therapy is a promising treatment strategy. Considering the central role of the epidermal growth factor receptor in cell proliferation and survival, there are indications that targeted agents like tyrosine kinase inhibitors,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe3d0bb6121e7c65467246b3b398ecc
https://doi.org/10.2298/ntrp1403233k